quetiapin ratiopharm 400 mg depottabletti
teva pharma b.v. - quetiapine fumarate - depottabletti - 400 mg - ketiapiini
albiomin 200 g/l infuusioneste, liuos
biotest pharma gmbh - albuminum ihmisen - infuusioneste, liuos - 200 g/l - albumiini
sutent
pfizer limited - sunitinibi - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiset aineet - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
resolor
takeda pharmaceuticals international ag ireland - prucalopride succinate - ummetus - muut ummetuslääkkeet - resolor on tarkoitettu oireenmukaista hoitoa kroonisen ummetuksen aikuisilla, joille laksatiivit eivät tuo toivottua lievitystä.
zyrtec 10 mg/ml tipat, liuos
ucb pharma oy finland - cetirizine dihydrochloride - tipat, liuos - 10 mg/ml - setiritsiini
vesicare 5 mg tabletti, kalvopäällysteinen
astellas pharma a/s - solifenacin succinate - tabletti, kalvopäällysteinen - 5 mg - solifenasiini
vesicare 10 mg tabletti, kalvopäällysteinen
astellas pharma a/s - solifenacin succinate - tabletti, kalvopäällysteinen - 10 mg - solifenasiini
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminohappoaineenvaihdunta, synnynnäiset virheet - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
elvanse 30 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 30 mg - lisdeksamfetamiini
elvanse 50 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 50 mg - lisdeksamfetamiini